JP2024524986A5 - - Google Patents

Info

Publication number
JP2024524986A5
JP2024524986A5 JP2023579119A JP2023579119A JP2024524986A5 JP 2024524986 A5 JP2024524986 A5 JP 2024524986A5 JP 2023579119 A JP2023579119 A JP 2023579119A JP 2023579119 A JP2023579119 A JP 2023579119A JP 2024524986 A5 JP2024524986 A5 JP 2024524986A5
Authority
JP
Japan
Prior art keywords
alkyl
ring
pharmaceutically acceptable
acceptable salt
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023579119A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024524986A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/034901 external-priority patent/WO2022272060A1/en
Publication of JP2024524986A publication Critical patent/JP2024524986A/ja
Publication of JP2024524986A5 publication Critical patent/JP2024524986A5/ja
Pending legal-status Critical Current

Links

JP2023579119A 2021-06-24 2022-06-24 Ｅｐ２アンタゴニスト化合物 Pending JP2024524986A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163214645P 2021-06-24 2021-06-24
US63/214,645 2021-06-24
PCT/US2022/034901 WO2022272060A1 (en) 2021-06-24 2022-06-24 Ep2 antagonist compounds

Publications (2)

Publication Number Publication Date
JP2024524986A JP2024524986A (ja) 2024-07-09
JP2024524986A5 true JP2024524986A5 (https=) 2025-07-02

Family

ID=84543943

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023579119A Pending JP2024524986A (ja) 2021-06-24 2022-06-24 Ｅｐ２アンタゴニスト化合物

Country Status (4)

Country Link
US (1) US20240182459A1 (https=)
EP (1) EP4359392A4 (https=)
JP (1) JP2024524986A (https=)
WO (1) WO2022272060A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4642450A2 (en) * 2022-12-28 2025-11-05 Reservoir Neuroscience, Inc. Ep2 antagonist compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201922256A (zh) * 2017-10-27 2019-06-16 中國大陸商浙江導明醫藥科技有限公司 治療淋巴樣惡性疾病之方法
CN114302746A (zh) * 2019-06-10 2022-04-08 Adc治疗有限公司 包含抗cd25抗体药物缀合物和另一剂的组合疗法

Similar Documents

Publication Publication Date Title
ES2940263T3 (es) Compuestos químicos
CN105764514B (zh) 作为tam族激酶抑制剂的氨基吡啶衍生物
TW202322819A (zh) 含氮的四環化合物、其製備方法及其在醫藥上的應用
TWI619715B (zh) 流感病毒複製之抑制劑
CN109810041B (zh) 卤代烯丙基胺类ssao/vap-1抑制剂及其应用
BR112020025073A2 (pt) moduladores de montagem de capsídeo da hepatite b
BR102018007822A2 (pt) composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
EP3490987A1 (en) Novel therapeutic agents for the treatment of hbv infection
ES3062921T3 (en) Preparation method for novel rho-related protein kinase inhibitor and intermediate in preparation method
CN117715897A (zh) 化合物及其作为cd38抑制剂的用途
ES2978573T3 (es) Compuestos antibacterianos
US20220144838A1 (en) Compounds as Inhibitors of Macrophage Migration Inhibitory Factor
HRP20211678T1 (hr) N-supstituirani derivati indola kao modulatori receptora pge2
JP2023538304A (ja) 化合物、組成物及び方法
JP2022502370A (ja) 置換ピリジニル化合物およびその使用
JP7216189B2 (ja) チアジアゾールｉｒａｋ４阻害剤
KR20240165430A (ko) Tea 도메인 패밀리 구성원들의 저분자 억제제들
JP2025020388A (ja) Ｂｃｒ－ａｂｌチロシンキナーゼの阻害のための５－及び６－アザインドール化合物
JP7551641B2 (ja) 置換ｎ－ヘテロアリール化合物及びその使用
KR20230112605A (ko) 키나아제 억제제 및 그의 용도
EP4702014A1 (en) Bifunctional compounds for degrading braf via ubiquitin proteosome pathway
JP2024524986A5 (https=)
TW202328119A (zh) 唑化合物
JP7642625B2 (ja) 免疫調節剤として有用な化合物
KR20240093673A (ko) 삼환계 gpr65 조절제